- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 62.61M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $14.19M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $14M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $11.59M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.28M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $8.61M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.74M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.82M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $36.24M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $36.26M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $25.41M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $21.6M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $50.78M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $47.37M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 54.43M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $45.19K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$4.83M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $19.63M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $23.48M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.11 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $9.28M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$6.09M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$4.66M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $6.87M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $2.12M |